Skip to content

Improving Management of Post-partum Haemorrhage With Quantra® System

Use of Quantra® System in Clinical Practice to Improve Management of Post-partum Haemorrhage : a Prospective Study

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05336838
Acronym
Quantralab
Enrollment
60
Registered
2022-04-20
Start date
2022-05-01
Completion date
2023-05-01
Last updated
2022-04-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post Partum Haemorrhage

Keywords

Post partum haemorrhage, Bleeding, Labour, Vaginal delivery, Caesarean section

Brief summary

Post partum haemorrhage is a concerning situation in maternity wards, though it is not the first cause of maternal mortality anymore. It has been already shown that low fibrinogen level is a major predictive factor of massive bleeding after delivery. In this situation, the early knowledge of fibrinogen level could enhance care of women experiencing post partum haemorrhage. In a cohort of women suffering from post partum haemorrhage, this study will evaluate whether assessing fibrinogen level would be faster using the Quantra® system than the standard coagulation test.

Interventions

None listed

Sponsors

University Hospital, Montpellier
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Women ≥ 18 years old Experiencing post partum haemorrhage ≥ 500 mL Within 24 hours after delivery

Exclusion criteria

* Previous anemia ≤ 7g/dL * Known bleeding disorders * Ongoing antiplatelets treatment * Ongoing anticoagulant treatment

Design outcomes

Primary

MeasureTime frameDescription
Comparison of delay in obtaining Quantra Fibrinogen Clot Stiffness result to standard fibrinogen level resultWhen post partum haemorrhage occurred, within 24 hours after deliveryComparison of delay in obtaining Quantra Fibrinogen Clot Stiffness result to standard fibrinogen level result

Secondary

MeasureTime frameDescription
Comparison of level of fibrinogen assessed by Quantra Fibrinogen Clot Stiffness to level of fibrinogen assessed by standard coagulation testWhen post partum haemorrhage occurred, within 24 hours after deliveryFibrinogen level assessed by Quantra and standard coagulation tests
Comparison of Quantra Clot Time result to Standard Kaolin Clotting time resultWhen post partum haemorrhage occurred, within 24 hours after deliveryCoagulation function assessed by Quantra and standard coagulation tests
Comparison of Platelet Clot Stiffness result to standard platelet count resultWhen post partum haemorrhage occurred, within 24 hours after deliveryPlatelet function assessed by Quantra and standard platelet count.
Rate of satisfaction of anesthetist in charge of patient assessed by Lickert scaleWhen post partum haemorrhage occurred, within 24 hours after deliveryRate of satisfaction of anesthetist in charge of patient assessed by Lickert scale \[1-Strongly disagree ; 2-Disagree ; 3-Neither agree nor disagree ; 4-Agree ; 5-Strongly agree

Contacts

Primary ContactJessie Grenié, MD
j-grenie@chu-montpellier.fr00330467336472

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026